Selective inhibition of RET mediated cell proliferation in vitro by the kinase inhibitor SPP86.

作者: John P Alao , Sona Michlikova , Peter Dinér , Morten Grøtli , Per Sunnerhagen

DOI: 10.1186/1471-2407-14-853

关键词:

摘要: Background The RET tyrosine kinase receptor has emerged as a target in thyroid and endocrine resistant breast cancer. We previously reported the synthesis of inhibitors with potent activity against RET. Herein, we have further investigated effect lead compound SPP86 on mediated signaling proliferation. Based these observations, hypothesized that may be useful for studying cellular

参考文章(64)
James A. McCubrey, Linda S. Steelman, William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Saverio Candido, Grazia Malaponte, Maria C. Mazzarino, Paolo Fagone, Ferdinando Nicoletti, Jörg Bäsecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Michele Milella, Agostino Tafuri, Francesca Chiarini, Camilla Evangelisti, Lucio Cocco, Alberto M. Martelli, Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance Oncotarget. ,vol. 3, pp. 1068- 1111 ,(2012) , 10.18632/ONCOTARGET.659
Giuliana Cassinelli, Enrica Favini, Debora Degl'Innocenti, Alessandro Salvi, Giuseppina De Petro, Marco A. Pierotti, Franco Zunino, Maria Grazia Borrello, Cinzia Lanzi, RET/PTC1-Driven Neoplastic Transformation and Proinvasive Phenotype of Human Thyrocytes Involve Met Induction and β-Catenin Nuclear Translocation Neoplasia. ,vol. 11, pp. 10- 21 ,(2009) , 10.1593/NEO.08916
William H. Chappell, Linda S. Steelman, Jacquelyn M. Long, Ruth C. Kempf, Stephen L. Abrams, Richard A. Franklin, Jörg Bäsecke, Franca Stivala, Marco Donia, Paolo Fagone, Graziella Malaponte, Maria C. Mazzarino, Ferdinando Nicoletti, Massimo Libra, Danijela Maksimovic-Ivanic, Sanja Mijatovic, Giuseppe Montalto, Melchiorre Cervello, Piotr Laidler, Michele Milella, Agostino Tafuri, Antonio Bonati, Camilla Evangelisti, Lucio Cocco, Alberto M. Martelli, James A. McCubrey, Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health Oncotarget. ,vol. 2, pp. 135- 164 ,(2011) , 10.18632/ONCOTARGET.240
David Bliman, Jesper R. Nilsson, Petronella Kettunen, Joakim Andréasson, Morten Grøtli, A Caged Ret Kinase Inhibitor and its Effect on Motoneuron Development in Zebrafish Embryos. Scientific Reports. ,vol. 5, pp. 13109- 13109 ,(2015) , 10.1038/SREP13109
Manuel Saiselet, Sébastien Floor, Maxime Tarabichi, Geneviève Dom, Aline Hébrant, Wilma C. G. van Staveren, Carine Maenhaut, Thyroid cancer cell lines: an overview Frontiers in Endocrinology. ,vol. 3, pp. 133- 133 ,(2012) , 10.3389/FENDO.2012.00133
Amit Arora, Eric M. Scholar, Role of Tyrosine Kinase Inhibitors in Cancer Therapy Journal of Pharmacology and Experimental Therapeutics. ,vol. 315, pp. 971- 979 ,(2005) , 10.1124/JPET.105.084145
Luca Mologni, Sara Redaelli, Andrea Morandi, Ivan Plaza-Menacho, Carlo Gambacorti-Passerini, Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase Molecular and Cellular Endocrinology. ,vol. 377, pp. 1- 6 ,(2013) , 10.1016/J.MCE.2013.06.025
Dong Wook Kim, Jung Hwan Hwang, Jae Mi Suh, Ho Kim, Jung Hun Song, Eun Suk Hwang, Il Young Hwang, Ki Cheol Park, Hyo Kyun Chung, Jin Man Kim, Jongsun Park, Brian A. Hemmings, Minho Shong, RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1. Molecular Endocrinology. ,vol. 17, pp. 1382- 1394 ,(2003) , 10.1210/ME.2002-0402
Takashi Kohno, Hitoshi Ichikawa, Yasushi Totoki, Kazuki Yasuda, Masaki Hiramoto, Takao Nammo, Hiromi Sakamoto, Koji Tsuta, Koh Furuta, Yoko Shimada, Reika Iwakawa, Hideaki Ogiwara, Takahiro Oike, Masato Enari, Aaron J Schetter, Hirokazu Okayama, Aage Haugen, Vidar Skaug, Suenori Chiku, Itaru Yamanaka, Yasuhito Arai, Shun-ichi Watanabe, Ikuo Sekine, Seishi Ogawa, Curtis C Harris, Hitoshi Tsuda, Teruhiko Yoshida, Jun Yokota, Tatsuhiro Shibata, KIF5B-RET fusions in lung adenocarcinoma Nature Medicine. ,vol. 18, pp. 375- 377 ,(2012) , 10.1038/NM.2644
Anne Boulay, Madlaina Breuleux, Christine Stephan, Caroline Fux, Cathrin Brisken, Maryse Fiche, Markus Wartmann, Michael Stumm, Heidi A. Lane, Nancy E. Hynes, The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. Cancer Research. ,vol. 68, pp. 3743- 3751 ,(2008) , 10.1158/0008-5472.CAN-07-5100